Ontario Lowers Colorectal Cancer Screening Age to 45, Opening Access for 1 Million
Updated
Updated · Medscape · Jun 25
Ontario Lowers Colorectal Cancer Screening Age to 45, Opening Access for 1 Million
3 articles · Updated · Medscape · Jun 25
Summary
July 1 marks Ontario’s rollout of publicly funded colorectal cancer screening for people aged 45 and older, with higher-risk patients eligible starting at 40.
The province said lowering the threshold from 50 responds to rising disease in younger adults and could expand early detection and treatment to as many as 1 million Ontarians.
Recent modeling cited in the report estimated the shift would prevent 15,070 colorectal cancer cases and 6,100 deaths between 2025 and 2071, while saving about $233 million over eligible cohorts’ lifetimes.
Ontario is only the second Canadian province after Prince Edward Island to adopt the lower age, even as the Canadian Cancer Society urges broader action and British Columbia weighs a similar move.
ColonCancerCheck will begin sending letters in early July directing eligible residents to an initial fecal immunochemical test, though physicians say participation remains a longstanding challenge.
Ontario now screens 1 million more for cancer. Is its healthcare system ready for the surge in follow-up colonoscopies?
As Ontario lowers the screening age, why do some national medical experts urge caution before a Canada-wide change?
Ontario Expands Colorectal Cancer Screening to Age 45: Addressing the Surge in Early-Onset Cases
Overview
Ontario has lowered the recommended age for colorectal cancer screening to 45, starting July 1, 2026. This policy expands eligibility for regular screening to all Ontarians aged 45 and older at average risk, building on the existing ColonCancerCheck program. The change is supported by strong evidence that earlier screening leads to earlier detection, which can improve outcomes by finding cancer at more treatable stages. Advocates believe this move will save lives and reduce long-term health-care costs, as identifying precancerous polyps or early-stage cancers allows for less invasive and more successful interventions.